Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

Podrobná bibliografie
Hlavní autoři:	Gillies, R, Delaney, D, Warren, B, Sharma, R, Middleton, MR
Médium:	Conference item
Vydáno:	2011

Podobné jednotky

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
Autor: Gillies, R, a další
Vydáno: (2012)

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.
Autor: Gillies, R, a další
Vydáno: (2012)

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.
Autor: Hatch, S, a další
Vydáno: (2014)

Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity
Autor: Graf, Nora, a další
Vydáno: (2012)

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
Autor: MacGregor, T, a další
Vydáno: (2018)

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection
Autor: Hatch, S, a další
Vydáno: (2014)

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
Autor: T. P. MacGregor, a další
Vydáno: (2018-05-01)

Use of DNA repair proteins translated from biomarker screening to predict overall survival in patients with esophageal cancer treated with oxaliplatin chemotherapy
Autor: Sharma, R, a další
Vydáno: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
Autor: Gillies, R, a další
Vydáno: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
Autor: Gillies, R, a další
Vydáno: (2012)

XPF-ERCC1: Linchpin of DNA crosslink repair
Autor: McHugh, PJ
Vydáno: (2020)

XPF-ERCC1: Linchpin of DNA crosslink repair.
Autor: Peter J McHugh
Vydáno: (2020-04-01)

Tissue-Specific DNA Repair Activity of ERCC-1/XPF-1
Autor: Mariangela Sabatella, a další
Vydáno: (2021-01-01)

Challenges in assessing response of oesophageal cancer to neoadjuvant therapy, and the potential of composite PET-CT and multimodal metrics.
Autor: Findlay, J, a další
Vydáno: (2017)

Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy.
Autor: Yang, J, a další
Vydáno: (2010)

Oesophageal and gastro-oesophageal junction tumours
Autor: Bird-Lieberman, E, a další
Vydáno: (2007)

Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
Autor: Anwaar Ahmad, a další
Vydáno: (2010-03-01)

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.
Autor: Findlay, J, a další
Vydáno: (2017)

Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
Autor: den Boer, RB, a další
Vydáno: (2020)

XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer
Autor: Ming-Yii Huang, a další
Vydáno: (2023-05-01)

Biochemical studies on the role of the XPF-ERCC1 endonuclease in repairing damaged DNA replication forks
Autor: Abdullah, U
Vydáno: (2015)

ERCC1/XPF Is Important for Repair of DNA Double-Strand Breaks Containing Secondary Structures
Autor: Shibo Li, a další
Vydáno: (2019-06-01)

Neoadjuvant chemotherapy for oesophageal carcinoma - a risk factor for postoperative pneumonia?
Autor: Millo, J, a další
Vydáno: (2003)

Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression
Autor: Kaina Bernd, a další
Vydáno: (2010-09-01)

Optimised oligonucleotide substrates to assay XPF-ERCC1 nuclease activity for the discovery of DNA repair inhibitors
Autor: Thomas, A, a další
Vydáno: (2019)

Oesophageal carcinoma: The prevalence of DNA tumour viruses and therapy
Autor: Sile Li, a další
Vydáno: (2022-06-01)

XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair.
Autor: Bhagwat, N, a další
Vydáno: (2009)

Function and Interactions of ERCC1-XPF in DNA Damage Response
Autor: Maryam Faridounnia, a další
Vydáno: (2018-12-01)

Acetylation of XPF by TIP60 facilitates XPF-ERCC1 complex assembly and activation
Autor: Jiajia Wang, a další
Vydáno: (2020-02-01)

Human SNM1a and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair
Autor: Wang, A, a další
Vydáno: (2011)

Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair.
Autor: Wang, A, a další
Vydáno: (2011)

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy
Autor: A. G. M. T. Powell, a další
Vydáno: (2020-08-01)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
Autor: Findlay, J, a další
Vydáno: (2016)

Effect of neoadjuvant chemotherapy on the immune microenvironment of gynaecological tumours
Autor: Jing Xue, a další
Vydáno: (2023-12-01)

Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis
Autor: Xin Zhang, a další
Vydáno: (2021-07-01)

Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
Autor: Gillies, R, a další
Vydáno: (2011)

Survival after curative chemoradiotherapy or neoadjuvant therapy and surgery converges in higher-risk patients with oesophageal cancer
Autor: Rana, M, a další
Vydáno: (2021)

A “Inscrição do Harém” de Xerxes (XPf): introdução crítica, tradução de XPf/OP para o português, comparação com XPf/AB e comentários
Autor: Matheus Treuk Medeiros de Araújo
Vydáno: (2024-05-01)

NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
Autor: Mukherjee, S, a další
Vydáno: (2017)

Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer
Autor: Gillies, R, a další
Vydáno: (2010)